Market Cap 69.61M
Revenue (ttm) 200,000.00
Net Income (ttm) -26.17M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -13,085.00%
Debt to Equity Ratio -0.21
Volume 54,500
Avg Vol 80,386
Day's Range N/A - N/A
Shares Out 11.78M
Stochastic %K 7%
Beta 0.62
Analysts Strong Sell
Price Target $30.43

Company Profile

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic...

Industry: Packaged Foods
Sector: Consumer Defensive
Phone: 801 676 9695
Website: clene.com
Address:
6550 South Millrock Drive, Suite G50, Salt Lake City, United States
paule815
paule815 Apr. 25 at 10:53 PM
$CLNN looking forward. To x10? Eh… Maybe next next month.
1 · Reply
fibonacci1170
fibonacci1170 Apr. 25 at 6:21 AM
$CLNN hopefully this will get us AA.
1 · Reply
fibonacci1170
fibonacci1170 Apr. 25 at 6:18 AM
$CLNN there are many neurown testimonials of patients going from being wheel-chair-bound to jogging and climbing stairs. Do we have such data with CLENE? CLENE failed to show any difference from placebo on patient functionality, yet shows 90% survival benefit based on Nfl biomarker data. How the hell is that possible? It seems cnmau8 makes patients live longer (which is important) but does not improve their physical functionality (which is also very important for quality of life). Is my assessment wrong? Does cnmau8 improve functionality? But why failed the primary endpoint? Are there any long-term testimonials like neurown? I don't trust the FDA.
0 · Reply
Woodman7
Woodman7 Apr. 24 at 11:14 PM
$CLNN - quick back of the envelope calculations, if Clene could get to a $1B valuation and diluted by 50% or less, I could make a $1M gain if I hold all of my 17,500 shares until then.
3 · Reply
Mulhollandr
Mulhollandr Apr. 24 at 9:42 PM
$CLNN last peep from me until next week. Short interest declined by 10%. Happy no Friday PR about fda minutes. There’s gonna be a very happy Monday soon. 🍀🍀🍀
1 · Reply
7m3835d3
7m3835d3 Apr. 24 at 8:38 PM
$CLNN not what we were hoping for for this week, but the next two weeks will be extremely exciting. Talk to everyone on Monday!
0 · Reply
Mulhollandr
Mulhollandr Apr. 24 at 6:48 PM
0 · Reply
Woodman7
Woodman7 Apr. 24 at 4:17 PM
$CLNN. $LUCD So I have only two biotech in my portfolio right now, Lucid Diagnostics and Clene. Both are waiting and waiting and waiting agonizingly for the next step in the process towards approval. Does it ever end??? But, I give both of them a very good shot of success over the upcoming month or so. 
1 · Reply
Woodman7
Woodman7 Apr. 24 at 4:11 PM
$CLNN - $CLNN - I’ve added 2500 shares so far in April. At 17,500 now. Cost basis around $6.30 now…Wish I hadn’t added at around $10 when it spiked in early Nov and I would be quite a bit lower. 
3 · Reply
neuroinvestor3
neuroinvestor3 Apr. 24 at 3:14 PM
$CLNN Is Chidozie making any money? what was his cost basis?
1 · Reply
Latest News on CLNN
Clene Transcript: Emerging Growth Virtual Conference

Feb 25, 2026, 1:45 PM EST - 2 months ago

Clene Transcript: Emerging Growth Virtual Conference


Clene to Present at the Emerging Growth Conference

Feb 19, 2026, 8:30 AM EST - 2 months ago

Clene to Present at the Emerging Growth Conference


Clene Transcript: Emerging Growth Conference 89

Jan 21, 2026, 3:10 PM EST - 3 months ago

Clene Transcript: Emerging Growth Conference 89


Clene Announces Registered Direct Offering of Over $28 Million

Jan 9, 2026, 8:30 AM EST - 3 months ago

Clene Announces Registered Direct Offering of Over $28 Million


Clene Transcript: Emerging Growth Conference 88

Dec 10, 2025, 4:25 PM EST - 4 months ago

Clene Transcript: Emerging Growth Conference 88


Clene Transcript: Study Update

Dec 3, 2025, 8:30 AM EST - 5 months ago

Clene Transcript: Study Update


Clene to Provide CNM-Au8® ALS Program Update

Dec 2, 2025, 5:39 PM EST - 5 months ago

Clene to Provide CNM-Au8® ALS Program Update


Clene Transcript: Emerging Growth Conference

Oct 23, 2025, 3:10 PM EDT - 6 months ago

Clene Transcript: Emerging Growth Conference


Clene Transcript: Emerging Growth Conference 85

Aug 20, 2025, 2:20 PM EDT - 8 months ago

Clene Transcript: Emerging Growth Conference 85


Clene to Present at the Canaccord 45th Annual Growth Conference

Aug 5, 2025, 8:30 AM EDT - 9 months ago

Clene to Present at the Canaccord 45th Annual Growth Conference


Clene Transcript: Emerging Growth Conference 84

Jul 17, 2025, 3:10 PM EDT - 10 months ago

Clene Transcript: Emerging Growth Conference 84


Clene Transcript: Q2 Virtual Investor Summit Event

Jun 10, 2025, 1:00 PM EDT - 11 months ago

Clene Transcript: Q2 Virtual Investor Summit Event


Clene Transcript: Emerging Growth Conference 82

May 21, 2025, 3:10 PM EDT - 1 year ago

Clene Transcript: Emerging Growth Conference 82


Clene Transcript: 37th Annual ROTH Conference

Mar 18, 2025, 12:30 PM EDT - 1 year ago

Clene Transcript: 37th Annual ROTH Conference


Clene to Present at the 37TH Annual Roth Conference

Mar 6, 2025, 8:30 AM EST - 1 year ago

Clene to Present at the 37TH Annual Roth Conference


Clene Announces 1-for-20 Reverse Stock Split

Jul 9, 2024, 8:00 AM EDT - 1 year ago

Clene Announces 1-for-20 Reverse Stock Split


Clene to Present at Upcoming May Conferences

May 14, 2024, 8:00 AM EDT - 2 years ago

Clene to Present at Upcoming May Conferences


paule815
paule815 Apr. 25 at 10:53 PM
$CLNN looking forward. To x10? Eh… Maybe next next month.
1 · Reply
fibonacci1170
fibonacci1170 Apr. 25 at 6:21 AM
$CLNN hopefully this will get us AA.
1 · Reply
fibonacci1170
fibonacci1170 Apr. 25 at 6:18 AM
$CLNN there are many neurown testimonials of patients going from being wheel-chair-bound to jogging and climbing stairs. Do we have such data with CLENE? CLENE failed to show any difference from placebo on patient functionality, yet shows 90% survival benefit based on Nfl biomarker data. How the hell is that possible? It seems cnmau8 makes patients live longer (which is important) but does not improve their physical functionality (which is also very important for quality of life). Is my assessment wrong? Does cnmau8 improve functionality? But why failed the primary endpoint? Are there any long-term testimonials like neurown? I don't trust the FDA.
0 · Reply
Woodman7
Woodman7 Apr. 24 at 11:14 PM
$CLNN - quick back of the envelope calculations, if Clene could get to a $1B valuation and diluted by 50% or less, I could make a $1M gain if I hold all of my 17,500 shares until then.
3 · Reply
Mulhollandr
Mulhollandr Apr. 24 at 9:42 PM
$CLNN last peep from me until next week. Short interest declined by 10%. Happy no Friday PR about fda minutes. There’s gonna be a very happy Monday soon. 🍀🍀🍀
1 · Reply
7m3835d3
7m3835d3 Apr. 24 at 8:38 PM
$CLNN not what we were hoping for for this week, but the next two weeks will be extremely exciting. Talk to everyone on Monday!
0 · Reply
Mulhollandr
Mulhollandr Apr. 24 at 6:48 PM
0 · Reply
Woodman7
Woodman7 Apr. 24 at 4:17 PM
$CLNN. $LUCD So I have only two biotech in my portfolio right now, Lucid Diagnostics and Clene. Both are waiting and waiting and waiting agonizingly for the next step in the process towards approval. Does it ever end??? But, I give both of them a very good shot of success over the upcoming month or so. 
1 · Reply
Woodman7
Woodman7 Apr. 24 at 4:11 PM
$CLNN - $CLNN - I’ve added 2500 shares so far in April. At 17,500 now. Cost basis around $6.30 now…Wish I hadn’t added at around $10 when it spiked in early Nov and I would be quite a bit lower. 
3 · Reply
neuroinvestor3
neuroinvestor3 Apr. 24 at 3:14 PM
$CLNN Is Chidozie making any money? what was his cost basis?
1 · Reply
Chris150
Chris150 Apr. 24 at 2:15 PM
$CLNN Someone keeps selling large amounts (2-5K shares for now) and dragging the price down. If it is our beloved Chidozie, expect a new 144 form later today or next week. It's getting ridiculous now with him to sell every day or so...
1 · Reply
GenX420
GenX420 Apr. 24 at 2:11 PM
$CLNN No bueno; below $6 and volume is pretty decent.
0 · Reply
biotrade123
biotrade123 Apr. 24 at 2:10 PM
$CLNN seems like the last minute ”minutes” are making some retail holders jittery😮
2 · Reply
Bbbb44444
Bbbb44444 Apr. 24 at 1:42 PM
$CLNN This entire admin is a bunch of mediocre white dudes with Dunning Kruger.
0 · Reply
Mulhollandr
Mulhollandr Apr. 24 at 1:03 PM
$CLNN easy to be frustrated and feel your patience slipping. Today we are 1 day closer to the most binary moment this company has ever had. We’ve done our research and have had great contributions to it by everyone on this board. The moment is within days. Evidence continues to support that we have picked the right horse. I’m still bullish that we have a winner. Good luck everyone. 🍀🍀🍀🍀🍀
0 · Reply
fibonacci1170
fibonacci1170 Apr. 24 at 12:30 PM
$CLNN when FDA takes the last minute to respond to 10-month pdufa, 6-month AA, 75-day type C meetings, or 30-day reviews, it shows its incompetence. It shows it's employees don't work iota on a daily basis, and respond at all at the last minute to avoid public backlash. Only the most washed up losers go on to work for FDA. 75+30 days for a simple yes/no to AA filing and then another 6 months to actually review the data... Is ludicrous. In private sector, you would be sacked for sleeping on the job, with an appraisal letter so damning you won't find another job ever. T-0 days.
2 · Reply
biotrade123
biotrade123 Apr. 23 at 9:24 PM
$CLNN is tomorrow the day this could move one way or another??
1 · Reply
biotrade123
biotrade123 Apr. 23 at 4:43 PM
$CLNN looks like the "minutes" will come out at the last minute?
1 · Reply
Bbbb44444
Bbbb44444 Apr. 23 at 1:42 PM
$CLNN Someone enlighten me here. If Chode-ozi can sell, can’t other execs buy? And why wouldn’t they to combat his nonsense?
2 · Reply
7m3835d3
7m3835d3 Apr. 22 at 10:32 PM
$CLNN https://invest.clene.com/static-files/a1e87e41-2924-4373-ae82-30cdb0e30485 So he sold everything from the past 144. He now has 297066 stocks left. The good news is that we went up even though he sold 104k shares in a short time. This will be over very soon!
2 · Reply
Mulhollandr
Mulhollandr Apr. 22 at 7:50 PM
$CLNN green is green but was hoping for more follow through. I’m hoping it’s just set up for next few sessions. RSI is recharged. 👍🏻
0 · Reply
Takeover24
Takeover24 Apr. 22 at 5:26 PM
$CLNN Currently sitting at $6.66 right now… Biotech investors: “this is either the devil’s price… or a sign we’re about to ascend.” 😈📈 FDA: silence Us refreshing every 3 minutes like it’s going to change the outcome: 👁️👄👁️ NDA clock ticking… let’s see if this thing goes to hell or heaven.
2 · Reply